Company / Working Capital
BioNexus Gene Lab Corp Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$4.9M
FY2025
5-year range
$4.0M / $6.4M
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from $830,997 in FY2019 to $6M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +1.3%.
Declined from $6M to $5M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +7.0%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +1.3%, indicating consistent growth.
- In FY2025, working capital decreased 10.1% year-over-year.
- Peak working capital was recorded in FY2023.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.9M | -10.1% |
| FY2024 | $5.5M | -14.6% |
| FY2023 | $6.4M | +59.7% |
| FY2022 | $4.0M | -16.7% |
| FY2021 | $4.8M | +4.5% |
| FY2020 | $4.6M | +455.0% |
| FY2019 | $831.0K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026